CN Patent

CN104507946A — 氘代依鲁替尼

Assigned to Concert Pharmaceuticals Inc · Expires 2015-04-08 · 11y expired

What this patent protects

本发明在一个实施方式中提供式I的化合物或其药学上可接受的盐，其中式I中显示的变量在说明书中进行了定义。

USPTO Abstract

本发明在一个实施方式中提供式I的化合物或其药学上可接受的盐，其中式I中显示的变量在说明书中进行了定义。

Drugs covered by this patent

deuruxolitinib-phosphate (DEURUXOLITINIB PHOSPHATE)

Patent Metadata

Patent number: CN104507946A
Jurisdiction: CN
Classification: —
Expires: 2015-04-08
Drug substance claim: No
Drug product claim: No
Assignee: Concert Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.